Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death.
about
The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive studyThe prescription pattern of Chinese herbal products that contain dang-qui and risk of endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan: a population-based studyA pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkersConquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence.Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD.How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis.Patients in Northwestern Turkey Prefer Herbs as Complementary Medicine after Breast Cancer Diagnosis.The Prescription Pattern of Chinese Herbal Products Containing Ginseng among Tamoxifen-Treated Female Breast Cancer Survivors in Taiwan: A Population-Based StudyPrescription pattern of chinese herbal products for breast cancer in taiwan: a population-based study.The Use of Complementary and Alternative Medicine by Korean Breast Cancer Women: Is It Associated with Severity of Symptoms?Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancerComplementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use.Patient decision-making about complementary and alternative medicine in cancer management: context and processA systematic review of beliefs involved in the use of complementary and alternative medicine.Lesson from comparison of CAM use by women with female-specific cancers to others: it's time to focus on interaction risks with CAM therapies.Familial and perceived risk of breast cancer in relation to use of complementary medicine.Perception of naturopathy for female patients with metastatic gynecological cancer: A qualitative study.Patient-centered care in cancer treatment programs: the future of integrative oncology through psychoeducation.Biologically based therapies are commonly self-prescribed by Brazilian women for the treatment of advanced breast cancer or its symptoms.Spirituality and use of complementary therapies for cure in advanced cancer.Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features.Performance care practices in complementary and alternative medicine by Thai breast cancer survivors: an ethnonursing study.Complementary and alternative medicine use among people with asthma and health-related quality of life.The 'cause' of my cancer, beliefs about cause among breast cancer patients and survivors who do and do not seek IO care.Attitudes and compliance of clinical management after genetic testing for hereditary breast and ovarian cancer among high-risk Southern Chinese females with breast cancer history.Complementary and alternative medications consumed by patients with head and neck carcinoma: a pilot study in Germany.Use of complementary therapies during chemotherapy: influence of patients' satisfaction with treatment decision making and the treating oncologist.
P2860
Q21260415-30DB972E-DBF6-4123-8198-D0337B258BC5Q28542574-20E1E1E6-EDFC-4CEE-B14F-6AA64CBADDFCQ33830320-52BC3A0B-9259-4B04-8830-EEE50188C2A6Q34036483-CA799816-30AB-4D6F-8400-BC00FE384D8AQ34125820-5625969B-17C1-4554-BEF5-DC3C67152E4DQ34226495-0202F0AF-76EE-4F50-B65A-0D844313023BQ34284307-451CFD73-6E0E-4E15-8ED2-FFEE624777ABQ35178096-562A7CF9-9A74-4F3B-9DF5-F50158781D3BQ36011012-B8445BB0-9040-499C-BAED-08E2543C332DQ36378693-EF103937-96E8-445F-896D-B40E7304EAF5Q36667556-91BF5C26-18C7-4254-B2FE-BCF6BCF5FFBDQ36763496-324F7C6B-B0DE-4642-849E-A6520554D7FBQ36860321-8F9BE0DB-60DB-4CE4-9B2B-C5DFA69A218FQ36980197-03DA6887-1A9F-41B2-9E61-63D0F3FBFF8EQ37019717-D045C278-ACC6-493A-92E2-5F7B1CFAC8C5Q37649250-47A903B2-09C4-465F-B177-9CDBCB27203EQ38561979-43875742-784D-4640-8956-30DAE69F6C76Q39069481-F906DCB8-2B8D-4B12-B5A5-08486A5A3F9FQ39215648-4112026E-1371-4CA7-9FC8-30E33F9C1CE0Q39833057-0C77D4E4-231D-451C-AE61-CD96543404EBQ43429415-74B115D8-FED7-467D-9DAD-26BB2A988676Q44436226-E008C2F9-38A0-4BF5-8B2A-6FD344EFCCB6Q48065895-BFA89F05-F94F-483D-801C-C59A2B2EA581Q50283276-C4CA27EA-9F03-4414-A15C-9B457EF34A35Q51154242-0C29CC4D-A265-4B81-AB7F-C76ACB04A9AEQ51360320-93CD2706-63D7-4085-90E1-6936AE12091DQ51914135-A420EC0E-1C2A-468F-884D-47B6CA7EDAD5
P2860
Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Complementary and alternative ...... breast cancer risk and death.
@en
Complementary and alternative ...... breast cancer risk and death.
@nl
type
label
Complementary and alternative ...... breast cancer risk and death.
@en
Complementary and alternative ...... breast cancer risk and death.
@nl
prefLabel
Complementary and alternative ...... breast cancer risk and death.
@en
Complementary and alternative ...... breast cancer risk and death.
@nl
P2093
P1476
Complementary and alternative ...... breast cancer risk and death.
@en
P2093
Carole Chartier
Eileen Rakovitch
George Dranitsaris
Jean-Philippe Pignol
Mark Clemons
Michelle Ezer
Sunil Verma
P2888
P304
P356
10.1007/S10549-004-3779-1
P407
P577
2005-03-01T00:00:00Z